Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Effect of Stribild vs Other Regimens in HIV-1
NCT02246998Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Dec 2014; status: completed.
02
Drugs
emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02246998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246998.